STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway

Amy Belton, Lingling Xian, Tait Huso, Michael Koo, Li Z. Luo, James Turkson, Brent D.G. Page, Patrick T. Gunning, Guosheng Liu, David L. Huso, Linda M.S. Resar

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)2681-2684
Number of pages4
JournalLeukemia and Lymphoma
Volume57
Issue number11
DOIs
StatePublished - Nov 1 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this